Nomura Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,500
Closed -$14.8M 1882
2026
Q1
$14.8M Buy
50,500
+25,400
+101% +$8.35M 0.04% 328
2025
Q4
$8.8M Buy
25,100
+6,600
+36% +$2.23M 0.01% 574
2025
Q3
$5.98M Buy
18,500
+17,800
+2,543% +$5.54M 0.01% 700
2025
Q2
$272K Sell
700
-6,800
-91% -$2.74M ﹤0.01% 1258
2025
Q1
$3.26M Buy
+7,500
New +$3.01M 0.01% 863
2024
Q2
Sell
-30,000
Closed -$15.6M 1827
2024
Q1
$15.6M Buy
+30,000
New +$14.9M 0.04% 323
2021
Q4
Sell
-10,000
Closed -$3.76M 2304
2021
Q3
$3.76M Buy
+10,000
New +$3.8M 0.01% 724
2020
Q4
Sell
-500
Closed -$134K 1552
2020
Q3
$134K Sell
500
-282,500
-100% -$76M ﹤0.01% 1201
2020
Q2
$74.4M Buy
+283,000
New +$75.5M 0.26% 51
2016
Q4
Sell
-37,500
Closed -$4.7M 1569
2016
Q3
$4.7M Buy
+37,500
New +$4.84M 0.01% 444
2014
Q4
Sell
-9,200
Closed -$1.09M 2392
2014
Q3
$1.09M Buy
9,200
+200
+2% +$22.9K ﹤0.01% 1404
2014
Q2
$969K Buy
9,000
+5,900
+190% +$608K ﹤0.01% 1451
2014
Q1
$309K Buy
+3,100
New +$280K ﹤0.01% 2074

Other funds holding ELV

Nomura Holdings's ELV Position: Q2 2026 in Review

Nomura Holdings increased its Elevance Health (ELV) stake by 1,681% in Q2 2026, buying an estimated $4.67M and bringing the position to 13,343 shares worth $5.16M. The position accounts for 0.01% of the portfolio, ranked #778.

Nomura Holdings first reported a position in ELV in Q2 2013 and has held it in 46 quarters since. The position peaked at $63.8M in Q3 2020. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Nomura Holdings held 13,343 shares of Elevance Health worth $5.16M as of Q2 2026.
  • Nomura Holdings bought 12,594 Elevance Health shares in Q2 2026, an estimated $4.67M.
  • Elevance Health made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #778 holding.
  • Nomura Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 46 quarters since.
  • Nomura Holdings's Elevance Health position peaked at $63.8M in Q3 2020.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.